cipla ltd
Cipla To Sell Two Roche Biologics In India
Cipla Ltd. and Roche Products (India) Private Limited have signed a distribution agreement for the promotion and sale of tocilizumab and bevacizumab.
Cipla Launches Hepcvir-L For HepC Genotype 1 Patients
Hepcvir-L will be provided to patients in India at the fraction of the cost of branded Ledipasvir-Sofosbuvir under a licensing agreement with Gilead Sciences Inc.
Cipla To Distribute Nasal Flu Vaccine In India
Cipla will market SII's NasovacS vaccine, a painless influenza vaccine that can boost herd immunity.
Generic Hepatitis Drug Launched In India As Hepcvir
Generics manufacturer Cipla has been granted the license to produce Sofosbuvir in India under the brand name Hepcvir.
Cipla Awarded US$189 Million Of Global Fund ARV Tender
Cipla has been selected by the Global Fund to produce anti-retroviral drugs for the next three years.
Cipla Gets FDA Approval For Generic HIV Drug
Tentative approval for a generic HIV drug for use outside of the United States has been granted to Indian manufacturer Cipla.
